The automated external defibrillators aed market has seen considerable growth due to a variety of factors.
• There has been significant growth in the market size of automated external defibrillators (AED) in the recent past. The market, valuing $1.84 billion in 2024, is predicted to rise to $1.98 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.6%.
The historic period has seen such growth due to factors such as heightened awareness and training, government efforts and rules, increasing cases of cardiac arrests, emphasis on safety at workplaces, and community-centric public access initiatives.
The automated external defibrillators aed market is expected to maintain its strong growth trajectory in upcoming years.
• The market for automated external defibrillators (AED) is predicted to experience solid expansion in the coming years, with its size forecasted to reach $2.52 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 6.3%.
This growth across the forecast period can be attributed to various factors such as worldwide health initiatives, a growing elderly population, the broadening of public access programs, corporate social responsibility initiatives, the rise of telemedicine and remote monitoring, and increased training schemes. Key trends expected during this forecast period encompass the development of AEDs to offer real-time feedback and guidance, the adoption of smart connectivity and remote monitoring, a focus on easy-to-use AED designs and user interfaces, the inclusion of pediatric modes in AEDs, the incorporation of CPR feedback technology, and the launch of AEDs with longer battery life.
The escalating instances of cardiac arrests is projected to enhance the automated external defibrillator (AED) market's growth. Sudden heart stoppage or irregular heartbeats, which can be immediately fatal, constitute cardiac arrest where the heart doesn't pump blood efficiently. Automated external defibrillator (AED) devices are utilised for treating heart arrests by delivering an electric shock to regain normal rhythm during abnormal beats. A report in September 2024 by British Heart Foundation (BHF), a UK charity specialising in research and awareness for heart and vascular diseases, stated that roughly 7.6 million UK residents suffer from heart and bloodstream disorders. By 2030, an additional one million people in the UK are expected to live with heart and circulatory diseases, and by 2040 this figure might go up to 2 million, supplementing the existing figures. Therefore, the increasing cases of cardiac arrest are fueling the automated external defibrillator (AED) market's growth. Rise in Aging Population Accelerates Automated External Defibrillator (AED) Market Growth
The automated external defibrillators (AED) market covered in this report is segmented –
1) By Type: Wearable, Non-Wearable
2) By Technology Type: Semi-Automatic, Fully Automatic
3) By Size Type: Standard, Pediatric
4) By Patient Type: Adults, Children
5) By End-User: Hospitals, Public Access Settings, Homecare settings, Pre-Hospitals Care, Emergency Medical Service Providers, Other End-Users
Subsegments:
1) By Wearable: Wearable AED Devices For Personal Use, Wearable AED Devices For Medical Use
2) By Non-Wearable: Manual AED Devices, Semi-Automatic AED Devices, Fully Automatic AED Devices
Leading firms in the automated external defibrillators (AED) market are making strides in technological advancements such as the integration of REALConnect technology, which features cellular, WiFi, GPS, and bluetooth capabilities, to deliver dependable services to consumers. REALConnect, a software platform, is crucial in the AED sector. It uses a variety of connectivity technologies, functioning as a wireless communication medium that enables different devices to interact with each other. In January 2023, for example, Avive Solutions Inc., a technology company based in the US that specialises in developing automated external defibrillators, introduced a FDA-approved product called Avive Connect automated external defibrillator (AED). This automatic handheld device combines cellular and WiFi connectivity, GPS technology, remote maintenance, and portability, making it an effective tool for treating cardiac arrest patients.
Major companies operating in the automated external defibrillators (aed) market report are:
• Koninklijke Philips N.V.
• Asahi Kasei Corporation
• Nihon Kohden Corporation
• Schiller AG
• Stryker Corporation
• Biotronik
• BPL Medical Technologies
• CU Medical System Inc.
• Mindray Bio-Medical Electronics Co. Ltd.
• ViVest Medical Technology Co. Ltd.
• AMI Italia
• Physio-Control Corporation
• CardiAid
• Kestra Medical Technologies Inc.
• ViVest Medical Technology Co. Ltd.
• CU Medical System Inc.
• DefiSign Life Systems Inc.
• Progetti S.r.l.
• MRL Inc.
• HeartSine Technologies Inc.
• BPL Medical Technologies
• CardiAid
• M&B Electronic Instruments Inc.
• Instramed Inc.
• Metrax GmbH
North America was the largest region in the automated external defibrillator market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated external defibrillators (aed) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.